ICICI Prudential US Bluechip Equity Fund - Growth - Direct Plan

Other Plans and Options
  • 0.48 %Nav, as on 17-04-2025

  • Previous Nav

  • Net Change on 17-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Direct Plan - Growth -131.17 -55.66 -2.02 7.61 12.70 14.97
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 -6.44 -11.14 4.44 6.28 13.50 7.82

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Direct Plan - Growth Jan 02, 2013 -2.02 7.61 12.70 1.19 3,019.13
Franklin Asian Equity Fund - Direct - Growth Jan 01, 2013 8.64 2.27 5.00 1.59 238.82
Aditya Birla Sun Life International Equity Fund - Growth - Direct Plan Jan 01, 2013 12.78 6.96 11.54 2.07 192.92

Fund Holdings as on 31-March-2025

  • Huntington Ingalls Industries Inc

  • West Pharmaceutical Services Inc

  • Corteva Inc

  • Zimmer Biomet Holdings Inc

  • Brown-Forman Corp

  • Veeva Systems Inc

  • Campbell Soup Co

  • Walt Disney

  • Boeing Co

  • Monolithic Power Systems Inc

  • Pfizer Inc

  • Danaher Corp

  • MarketAxess Holdings Inc

  • US Bancorp Inc

  • Constellation Brands Inc

  • Allegion plc

  • Estee Lauder Cos Inc

  • International Flavors & Fragrances Inc

  • NXP Semiconductors NV

  • Medtronic Plc

  • Agilent Technologies Co Ltd

  • Microchip Technology Inc.

  • Adobe Inc

  • Comcast Corporation

  • United Parcel Service Inc

  • Nike Inc

  • TRANSUNION

  • Bio-Rad Laboratories Inc

  • Charles Schwab Corp

  • Alphabet Inc

  • Net Current Assets

  • Mondelez International Inc

  • Amazon com

  • Equifax Inc.

  • Northrop Grumman Corp

  • Synopsys Inc

  • Cadence Design Systems Inc

  • Manhattan Associates Inc

  • Microsoft Corp

  • Gilead Sciences Inc.

  • Oracle Corp

  • Thermo Fisher Scientific Inc

  • Lam Research Corporation

  • Merck & Co Inc

  • Biogen Inc

  • Applied Material (US)

  • Amgen Inc

  • Bristol-Myers Squibb Co

  • Autodesk

  • Masco Corp.

  • Kenvue Inc

  • Altria Group Inc

  • TERADYNE INC

  • Occidental Petroleum Corp

  • Qualcomm Inc.

  • Epam Systems Inc

  • IDEX Corp

  • Freeport-McMoRan Inc

  • Salesforce.Com Inc

  • Yum China Holdings Inc.

  • Globant SA

  • ASML Holding NV-NY REG SHS

  • The Clorox Company

  • TREPS

View More

  • Miscellaneous

View More

  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 02-Jan-2013 and currently has an AUM of ₹3,019.13 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹0.29(0.48%)yesterday to ₹61.1.

Among its top 3 holdings the fund has exposure to Huntington Ingalls Industries Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Ritesh Lunawat and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100